TSSG researchers provide new hope for Alzheimer’s patients

Alzheimers_shutterstock_567396706-718x523

Image: Ocskay Mark/Shutterstock

Researchers at TSSG in Ireland’s south-east are conducting research into rewiring the brain to cure Alzheimer’s disease.

Combining nanotechnology and biotechnology, researchers at TSSG at Waterford Institute of Technology are on the brink of discovering a new way of treating Alzheimer’s.

The news comes on the heels of researchers at Trinity College Dublin discovering the hidden secrets of how Alzheimer’s and Parkinson’s form in the brain.

Alzheimer’s disease is the sixth-leading cause of death for all ages and the fifth-leading cause of death for those over the age of 65. It carries a cost of $226bn in the US alone.

Until now, treatment has come in the form of symptom-preventing drugs that neglect the progression of the disease.

A team led by Michael Barros at TSSG have found that nanoparticles can potentially bypass the blood-brain barrier and, if combined with biotechnology and how problems are solved on computer and telecoms networks, a new approach could be found to treat – and potentially cure – the disease.

To read more on this article and view video interview please click HERE

Written and published by John Kennedy, Editor, Silicon Republic